ZOM
$0.13
Revenue | $7.34Mn |
Net Profits | $-22.41Mn |
Net Profit Margins | -305.38% |
Zomedica Corp’s revenue jumped 33.84% since last year same period to $7.34Mn in the Q1 2024. On a quarterly growth basis, Zomedica Corp has generated 0% jump in its revenue since last 3-months.
Zomedica Corp’s net profit fell -250.92% since last year same period to $-22.41Mn in the Q1 2024. On a quarterly growth basis, Zomedica Corp has generated 0% jump in its net profits since last 3-months.
Zomedica Corp’s net profit margin fell -162.19% since last year same period to -305.38% in the Q1 2024. On a quarterly growth basis, Zomedica Corp has generated 0% jump in its net profit margins since last 3-months.
EPS Estimate Current Year | -0.01 |
Zomedica Corp’s earning per share (EPS) estimates for the current year stand at -0.01.
Earning Per Share (EPS) | -0.01 |
Return on Assets (ROA) | -0.07 |
Return on Equity (ROE) | -0.14 |
Zomedica Corp’s earning per share (EPS) jumped 0% since last year same period to -0.01 in the Q1 2024. This indicates that the Zomedica Corp has generated 0% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Zomedica Corp’s return on assets (ROA) stands at -0.07.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Zomedica Corp’s return on equity (ROE) stands at -0.14.
Earnings Date | Estimated EPS | Reported EPS | Surprise % |
---|---|---|---|
2023-03-15 | -0.01 | -0.01 | 0% |